Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.

Gynecologic oncology - 1 Jul 2016

Dai Donghai, Thiel Kristina W, Salinas Erin A, Goodheart Michael J, Leslie Kimberly K, Gonzalez Bosquet Jesus

Abstract excerpt

OBJECTIVE: Patients with endometrioid endometrial cancer are stratified as high risk and low risk for extrauterine disease by surgical staging. Since patients with low-grade, minimally invasive disease do not benefit from comprehensive staging, pre-surgery stratification into a risk category may prevent unnecessary surgical staging in low risk patients. Our objective was to develop a predictive model to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Neoplasm Staging

Share to Precision Medicine

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 27181389
DOI: 10.1016/j.ygyno.2016.05.012
PMCID: PMC5257080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.PMID 27181389Read ↗

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.Semantic proximity Read ↗

Associations between molecular subtypes and high-risk pathological factors in endometrial cancer.Semantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort StudySemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read ↗

The Advantages of NGS Molecular Classification in Endometrial Cancer DiagnosisSemantic proximity Read ↗

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classificationSemantic proximity Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read ↗

Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk FactorsSemantic proximity Read ↗

Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial CarcinomaSemantic proximity Read ↗

One-stop molecular classification of endometrial carcinoma using comprehensive next-generation sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.